MSD (Belgium)

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1200/jco.18.00149 Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
https://doi.org/10.1007/bf01871102 Amiloride and its analogs as tools in the study of ion transport
https://doi.org/10.1056/nejm200008313430902 Alendronate for the Treatment of Osteoporosis in Men
https://doi.org/10.1016/j.jtho.2020.06.015 A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407
https://doi.org/10.1007/pl00004171 Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study
https://doi.org/10.1080/07853890.2017.1407035 Understanding modern-day vaccines: what you need to know
https://doi.org/10.1359/jbmr.091035 Odanacatib, a cathepsin-K inhibitor for osteoporosis: A two-year study in postmenopausal women with low bone density
https://doi.org/10.1073/pnas.0703472104 [18F]MK-9470, a positron emission tomography (PET) tracer forin vivohuman PET brain imaging of the cannabinoid-1 receptor
https://doi.org/10.1016/j.kint.2022.06.013 Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence
https://doi.org/10.1002/jbmr.212 Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect
https://doi.org/10.1093/annonc/mdl019 Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment
https://doi.org/10.1136/annrheumdis-2012-203201 Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1
https://doi.org/10.1136/ard.2011.152223 Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study
https://doi.org/10.1002/jbmr.1695 Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study
https://doi.org/10.3389/fpubh.2021.747787 The Relationship Between the COVID-19 Pandemic and Vaccine Hesitancy: A Scoping Review of Literature Until August 2021
https://doi.org/10.1002/pds.1435 A quantitative approach to benefit-risk assessment of medicines – part 1: the development of a new model using multi-criteria decision analysis
https://doi.org/10.1124/jpet.113.206458 In Vivo Quantification of Calcitonin Gene-Related Peptide Receptor Occupancy by Telcagepant in Rhesus Monkey and Human Brain Using the Positron Emission Tomography Tracer [11C]MK-4232
https://doi.org/10.1210/jc.2012-2972 Bone Density, Turnover, and Estimated Strength in Postmenopausal Women Treated With Odanacatib: A Randomized Trial
https://doi.org/10.1136/annrheumdis-2012-201777 Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study
https://doi.org/10.2967/jnumed.118.208215 Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with 18F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles
https://doi.org/10.1080/13696998.2018.1521416 Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US
https://doi.org/10.1016/s2352-3018(19)30372-8 Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial
https://doi.org/10.1097/bor.0b013e3283620e04 Hip disease in ankylosing spondylitis
https://doi.org/10.1002/jps.3030490616 The Hydrolysis of Hydrocortisone Phosphate in Essentially Neutral Solutions**Received August 21, 1959, from the Merck, Sharp & Dohme Research Laboratories, West Point, Pa.
https://doi.org/10.1080/03007995.2019.1571297 Cost-effectiveness of pembrolizumab in combination with chemotherapy versus chemotherapy and pembrolizumab monotherapy in the first-line treatment of squamous non-small-cell lung cancer in the US
https://doi.org/10.1111/j.1365-2125.2012.04471.x Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics – results from single oral dose studies in healthy volunteers
https://doi.org/10.3851/imp2920 Safety, Tolerability and Pharmacokinetics of Doravirine, a Novel HIV Non-Nucleoside Reverse Transcriptase Inhibitor, after Single and Multiple doses in Healthy Subjects
https://doi.org/10.1016/j.jpeds.2015.02.043 Efficacy and Safety of Ezetimibe Monotherapy in Children with Heterozygous Familial or Nonfamilial Hypercholesterolemia
https://doi.org/10.5665/sleep.5168 On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers
https://doi.org/10.1186/s12883-020-01672-w Machine learning analysis of motor evoked potential time series to predict disability progression in multiple sclerosis
https://doi.org/10.1002/jbmr.2194 Effects of Odanacatib on the Radius and Tibia of Postmenopausal Women: Improvements in Bone Geometry, Microarchitecture, and Estimated Bone Strength
https://doi.org/10.1136/annrheumdis-2019-216487 Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study
https://doi.org/10.1038/s41591-021-01479-3 Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial
https://doi.org/10.1097/qad.0000000000000876 A randomized, double-blind, placebo-controlled, short-term monotherapy study of doravirine in treatment-naive HIV-infected individuals
https://doi.org/10.3109/02770900903104540 Clinical Studies of Combination Montelukast and Loratadine in Patients with Seasonal Allergic Rhinitis
https://doi.org/10.1186/s12889-023-15939-7 Pneumococcal vaccination coverage and adherence to recommended dosing schedules in adults: a repeated cross-sectional study of the INTEGO morbidity registry
https://doi.org/10.1177/09622802241289559 Is inverse probability of censoring weighting a safer choice than per-protocol analysis in clinical trials?
https://doi.org/10.2807/1560-7917.es.2024.29.45.2400108 Non-invasive Streptococcus pneumoniae infections are associated with different serotypes than invasive infections, Belgium, 2020 to 2023
https://doi.org/10.1016/s0190-9622(99)80051-6 The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia
https://doi.org/10.1046/j.1365-2222.1999.00447.x The effect of montelukast (MK‐0476), a cysteinyl leukotriene receptor antagonist, on allergen‐induced airway responses and sputum cell counts in asthma
https://doi.org/10.1016/s0959-8049(00)00416-0 Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis
https://doi.org/10.1159/000020356 Prostate Volume and Serum Prostate–Specific Antigen as Predictors of Acute Urinary Retention
https://doi.org/10.1016/s0090-4295(01)01155-4 Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: a comprehensive analysis of the pooled placebo groups of several large clinical trials
https://doi.org/10.1097/00008571-200104000-00006 In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics
https://doi.org/10.1159/000008094 Comparison of Rizatriptan 10 mg vs. Naratriptan 2.5 mg in Migraine
https://doi.org/10.1359/jbmr.2000.15.4.754 Effects of Alendronate on Bone Quality and Remodeling in Glucocorticoid-Induced Osteoporosis: A Histomorphometric Analysis of Transiliac Biopsies
https://doi.org/10.1111/1541-0420.00012 A Causal Proportional Hazards Estimator for the Effect of Treatment Actually Received in a Randomized Trial with All‐or‐Nothing Compliance
https://doi.org/10.1002/jps.3030490417 Some Pharmaceutical Properties of Novobiocin **Received August 21, 1959, from Merck Sharp and Dohme Research Laboratories, West Point, Pa.
https://doi.org/10.1016/j.jaci.2009.08.011 Analysis of behavior-related adverse experiences in clinical trials of montelukast
https://doi.org/10.1111/j.1526-4610.2010.01799.x Long‐Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial
https://doi.org/10.1007/bf01067905 Pharmacokinetics of diphenhydramine in man
https://doi.org/10.1016/j.jaci.2009.08.010 Reports of suicidality in clinical trials of montelukast
https://doi.org/10.1159/000067018 Crossover Comparison of Efficacy and Preference for Rizatriptan 10 mg versus Ergotamine/Caffeine in Migraine
https://doi.org/10.1016/j.amjcard.2011.03.079 Safety and Efficacy of Ezetimibe Added on to Rosuvastatin 5 or 10 mg Versus Up-Titration of Rosuvastatin in Patients With Hypercholesterolemia (the ACTE Study)
https://doi.org/10.1111/j.1742-1241.2009.02022.x Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study
https://doi.org/10.1359/jbmr.2000.15.3.586 The Effect of Alendronate on Bone Mass After Distal Forearm Fracture
https://doi.org/10.1136/annrheumdis-2013-203460 Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2
https://doi.org/10.1016/j.bja.2018.05.056 Hypersensitivity incidence after sugammadex administration in healthy subjects: a randomised controlled trial
https://doi.org/10.1111/j.1365-2125.2007.02939.x Reproducibility of the capsaicin‐induced dermal blood flow response as assessed by laser Doppler perfusion imaging
https://doi.org/10.1038/clpt.2011.246 A Randomized, Placebo-Controlled Study of the Effects of Telcagepant on Exercise Time in Patients With Stable Angina
https://doi.org/10.1002/sim.4780060603 Evaluating the efficacy of a combination therapy
https://doi.org/10.1007/s00259-009-1340-5 Kinetic analysis of the cannabinoid-1 receptor PET tracer [18F]MK-9470 in human brain
https://doi.org/10.1016/j.amjcard.2013.08.031 Efficacy and Safety of Ezetimibe Added to Atorvastatin Versus Atorvastatin Uptitration or Switching to Rosuvastatin in Patients With Primary Hypercholesterolemia
https://doi.org/10.1007/s00467-012-2372-9 Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome
https://doi.org/10.1038/sj.clpt.6100345 Pharmacokinetics, Pharmacodynamics, and Safety of a Prostaglandin D2 Receptor Antagonist
https://doi.org/10.1038/clpt.2012.20 UGT2B17 Genetic Polymorphisms Dramatically Affect the Pharmacokinetics of MK-7246 in Healthy Subjects in a First-in-Human Study
https://doi.org/10.1038/clpt.2012.62 Equivalent Dynamic Human Brain NK1-Receptor Occupancy Following Single-Dose i.v. Fosaprepitant vs. Oral Aprepitant as Assessed by PET Imaging
https://doi.org/10.1111/j.1742-1241.2010.02370.x Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia
https://doi.org/10.2165/00044011-200424060-00003 Weekly Oral Alendronic Acid in Male Osteoporosis
https://doi.org/10.1002/hbm.25247 Brain dysconnectivity relates to disability and cognitive impairment in multiple sclerosis
https://doi.org/10.1016/j.reuma.2013.12.006 ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy
https://doi.org/10.1046/j.1365-2125.1999.00011.x The effects of moclobemide on the pharmacokinetics of the 5‐HT1B/1D agonist rizatriptan in healthy volunteers
https://doi.org/10.1007/s00520-007-0349-1 Cost-effectiveness analysis of aprepitant in the prevention of chemotherapy-induced nausea and vomiting in Belgium
https://doi.org/10.1002/art.40551 Association of Inflammatory Bowel Disease and Acute Anterior Uveitis, but Not Psoriasis, With Disease Duration in Patients With Axial Spondyloarthritis
https://doi.org/10.1002/clc.4960181107 Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia
https://doi.org/10.3109/13625187.2011.625882 Does structured counselling influence combined hormonal contraceptive choice?
https://doi.org/10.1136/annrheumdis-2013-203229 Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study
https://doi.org/10.1016/j.vaccine.2023.03.036 Divergent COVID-19 vaccine policies: Policy mapping of ten European countries
https://doi.org/10.5664/jcsm.27707 Effect of Gaboxadol on Patient-reported Measures of Sleep and Waking Function in Patients with Primary Insomnia: Results from Two Randomized, Controlled, 3-month Studies
https://doi.org/10.1007/s11307-019-01367-w Preclinical Safety Evaluation and Human Dosimetry of [18F]MK-6240, a Novel PET Tracer for Imaging Neurofibrillary Tangles
https://doi.org/10.1111/cea.13481 Rhinovirus‐16 induced temporal interferon responses in nasal epithelium links with viral clearance and symptoms
https://doi.org/10.1093/rheumatology/kez542 An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databases
https://doi.org/10.1126/science.1225702 Getting HIV Treatment to the Most People
https://doi.org/10.1177/1479164112465212 A comparison of efficacy and safety of an ezetimibe/simvastatin combination compared with other intensified lipid-lowering treatment strategies in diabetic patients with symptomatic cardiovascular disease
https://doi.org/10.1097/qai.0000000000003135 A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial of Radiopaque Islatravir-Eluting Subdermal Implants for Pre-exposure Prophylaxis Against HIV-1 Infection
https://doi.org/10.1016/j.sleep.2007.06.006 Efficacy of the selective extrasynaptic GABAA agonist, gaboxadol, in a model of transient insomnia: A randomized, controlled clinical trial
https://doi.org/10.1111/cts.12728 Ubrogepant Is Not Associated With Clinically Meaningful Elevations of Alanine Aminotransferase in Healthy Adult Males
https://doi.org/10.1017/s0266462321000131 Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements
https://doi.org/10.1111/bcp.12547 Characterizing the PK/PD relationship for inhibition of capsaicin‐induced dermal vasodilatation by MK‐3207, an oral calcitonin gene related peptide receptor antagonist
https://doi.org/10.1016/j.lungcan.2021.03.020 Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/−bevacizumab for the first-line treatment of non-squamous NSCLC: A matching-adjusted indirect comparison
https://doi.org/10.2967/jnumed.115.159715 Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18F-FDG PET/CT
https://doi.org/10.1093/rheumatology/kew230 Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristics
https://doi.org/10.1080/20016689.2021.1964791 Accelerating patient access to oncology medicines with multiple indications in Europe
https://doi.org/10.1080/10428194.2019.1602262 Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma
https://doi.org/10.1111/j.1749-6632.1962.tb30562.x THE REACTION OF THIAMINE WITH CARBONYL COMPOUNDS
https://doi.org/10.1111/ijcp.12315 Prevalence of persistent lipid abnormalities in statin‐treated patients: Belgian results of the Dyslipidaemia International Study ( DYSIS )
https://doi.org/10.1016/j.rmed.2022.107065 Effects of an inhaled soluble guanylate cyclase (sGC) stimulator MK-5475 in pulmonary arterial hypertension (PAH)
https://doi.org/10.3109/02770903.2010.520100 A Phase I Randomized, Placebo-Controlled, Dose-Exploration Study of Single-Dose Inhaled Montelukast in Patients with Chronic Asthma
https://doi.org/10.3389/fphar.2021.628434 Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in Belgium
https://doi.org/10.3389/fpubh.2023.1032385 Public health impact and return on investment of Belgium’s pediatric immunization program